Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM2 | P50570 | 4/20 | 0.68 |
| ▸ | HTR6 | P50406 | 7/20 | 0.59 |
| ▸ | PRKCA | P17252 | 6/20 | 0.49 |
| ▸ | PRKACA | P17612 | 3/20 | 0.49 |
| ▸ | PRKACG | P22612 | 3/20 | 0.49 |
| ▸ | PRKACB | P22694 | 3/20 | 0.49 |
| ▸ | PIM1 | P11309 | 2/20 | 0.49 |
| ▸ | PRKCB | P05771 | 5/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 4/20 | 0.47 |
| ▸ | PRKCH | P24723 | 3/20 | 0.46 |
| ▸ | PRKCQ | Q04759 | 3/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.45 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.45 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | PRKCG | P05129 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CDK1 | P06493 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13908036 | 0.86 | DNM2 (0.76) | DNM2HTR6PRKCAPRKACAPRKACG | |
| SCHEMBL13908035 | 0.83 | DNM2 (0.60) | DNM2HTR6PRKCAPRKACAPRKACG | |
| SCHEMBL25474234 | 0.81 | DNM2 (1.00) | DNM2HTR6PRKCAPRKACAPRKACG | |
| SCHEMBL1093927 | 0.80 | CNR2 (0.48) | DNM2HTR6MEN1TSHRKMT2A | |
| SCHEMBL14204507 | 0.77 | DNM2 (0.55) | DNM2HTR6PRKCAPRKACAPRKACG | |
| SCHEMBL8086295 | 0.77 | ICMT (0.71) | DNM2HTR6PRKCAPRKACAPRKACG | |
| SCHEMBL1092646 | 0.77 | CYP19A1 (0.51) | DNM2HTR6MEN1TP53KMT2A | |
| SCHEMBL13806549 | 0.77 | PRKCA (0.53) | DNM2HTR6PRKCAPRKACAPRKACG | |
| SCHEMBL20307301 | 0.76 | HTR6 (0.81) | HTR6 | |
| SCHEMBL31544897 | 0.76 | HTR6 (0.71) | DNM2HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142547-A1 | COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE INFECTION | ABIVAX (FR) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142547-A1 | COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE INFECTION | ACE, ACE2, SARS1 | DNM2 1392/4885HTR6 2922/4885PRKCA 1564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.